Caris Life Sciences, Inc. (CAI) insider trading.
In Q3 2026, insiders at Caris Life Sciences, Inc. reported 17 non-derivative transactions on 12 Forms 3, 4 and 5: 1 open-market purchase worth $990K and 5 sales worth $27.2M.
- Transactions
- 17
- Purchases (P)
- 1
- Sales (S)
- 5
- Net shares, P minus S
- -936,712
- Insiders
- 11
- Last filed
- 2026-09-23
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Spetzler David Baxley | Officer · President | 5 | 0 | 3 |
| Brille Brian J | Director, Officer · See Remarks | 2 | 0 | 1 |
| Halbert Jon | Director | 2 | 1 | 0 |
| Denton John Russel | Officer · See Remarks | 1 | 0 | 1 |
| Johansen Laura I | Director | 1 | 0 | 0 |
| Castleman Peter M | Director | 1 | 0 | 0 |
| Phillips T Danny | Director | 1 | 0 | 0 |
| Gilliam Joseph E | Director | 1 | 0 | 0 |
| Vacirca Jeff L | Director | 1 | 0 | 0 |
| Minor Lloyd | Director | 1 | 0 | 0 |
| Fredrickson David Paul | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-22 | Denton John Russel | S (D) | 7,500 | $31.82 | 174,855 | Form 4 |
| 2026-09-17 | Brille Brian J | S (D) | 400,000 | $30.33 | 230,303 | Form 4 |
| 2026-09-17 | Brille Brian J | M (A) | 400,000 | $2.44 | 630,303 | Form 4 |
| 2026-09-04 | Spetzler David Baxley | S (D) | 119,212 | $24.76 | 1,182,871 | Form 4 |
| 2026-09-04 | Spetzler David Baxley | M (A) | 250,000 | $2.44 | 1,302,083 | Form 4 |
| 2026-09-03 | Spetzler David Baxley | M (A) | 1,000,000 | $2.44 | 1,530,083 | Form 4 |
| 2026-09-03 | Spetzler David Baxley | S (D) | 393,100 | $24.76 | 1,136,983 | Form 4 |
| 2026-09-03 | Spetzler David Baxley | S (D) | 84,900 | $25.32 | 1,052,083 | Form 4 |
| 2026-08-14 | Halbert Jon | A (A) | 13,192 | $0 | 131,813 | Form 4 |
| 2026-08-14 | Johansen Laura I | A (A) | 13,192 | $0 | 343,897 | Form 4 |
| 2026-08-14 | Castleman Peter M | A (A) | 13,192 | $0 | 29,321 | Form 4 |
| 2026-08-14 | Phillips T Danny | A (A) | 13,192 | $0 | 133,060 | Form 4 |
| 2026-08-14 | Gilliam Joseph E | A (A) | 13,192 | $0 | 29,321 | Form 4 |
| 2026-08-14 | Vacirca Jeff L | A (A) | 13,192 | $0 | 62,863 | Form 4 |
| 2026-08-14 | Minor Lloyd | A (A) | 13,192 | $0 | 31,813 | Form 4 |
| 2026-08-14 | Fredrickson David Paul | A (A) | 13,192 | $0 | 31,813 | Form 4 |
| 2026-05-15 | Halbert Jon | P (A) | 68,000 | $14.56 | 704,598 | Form 4 |
Transaction codes in this quarter
Get CAI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2019410&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CAI company page · Caris Life Sciences, Inc. on SEC.gov
Questions
Are insiders buying or selling Caris Life Sciences, Inc. (CAI)?
In Q3 2026, insiders at Caris Life Sciences, Inc. reported 17 non-derivative transactions on 12 Forms 3, 4 and 5: 1 open-market purchase worth $990K and 5 sales worth $27.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Caris Life Sciences, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cai.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.